A novel mutation in antithrombin gene results in hereditary antithrombin deficiency.
- Author:
Fu-Hua ZHANG
1
;
Qiu-Lan DING
;
Jing-Sheng WU
;
Rong-Fu ZHOU
;
Xue-Feng WANG
;
Xiu-Cai XU
Author Information
- Publication Type:Case Reports
- MeSH: Antithrombin III Deficiency; genetics; Antithrombins; genetics; Blood Coagulation Tests; Female; Humans; Male; Mutation; Pedigree; Polymerase Chain Reaction; Sequence Analysis, DNA
- From: Chinese Journal of Hematology 2006;27(9):598-601
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo investigate the antithrombin (AT) activity (AT: A) and AT antigen (AT: Ag) level in a Chinese family with type I antithrombin (AT) deficiency, and to explore the molecular mechanism of AT deficiency.
METHODSImmuno-nephelometry and chromogenic assay were used to detect the plasma level of AT: A and AT: Ag, respectively. Genomic DNA was isolated from the peripheral blood, and all the seven exons and exon-intron boundaries of AT gene were amplified by PCR and direct sequencing.
RESULTSThe plasma levels of AT: A and AT: Ag of the proband were 45% and 97 mg/L, respectively, which led to a type I AT deficiency. A heterozygous T to A mutation was found at nucleotide 9833 in exon 5 resulting in a Tyr363Stop nonsense mutation. The sequencing results from the pedigree indicated that four other members also had this mutation.
CONCLUSIONThis heterozygous nonsense mutation of T9833A in exon 5 resulting in venous thrombosis is a novel genetic defect of hereditary AT deficiency, which has not been described before.